← Back to Screener
Humacyte, Inc. Warrant (HUMAW)
Price$0.05
Momentum ScoreF
Favorite Metrics
Price vs S&P 500 (26W)-79.50%
Price vs S&P 500 (4W)-32.41%
VGM Score7.12
All Metrics
Price vs S&P 500 (YTD)-48.47%
10-Day Avg Trading Volume0.01M
3-Month Avg Trading Volume0.01M
52-Week High$0.60
26-Week Price Return-71.58%
13-Week Price Return-45.29%
3-Month Return Std Dev254.97%
Year-to-Date Return-42.37%
5-Day Price Return-22.75%
Month-to-Date Return-33.09%
Price vs S&P 500 (13W)-53.54%
Beta2.66x
52-Week Low$0.04
mGradeF
vgmGradeF
Show chart for
Industry Peers — Biological Products(178)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
HUMAWHumacyte, Inc. Warrant | — | — | F | $0.05 |
| AMGNAmgen Inc | C | C | C | $349.58 |
| GILDGilead Sciences Inc | C | B | C | $129.16 |
| ARGXargenx SE American Depositary Shares | D | A | B | $891.32 |
| RVMDRevolution Medicines, Inc. Common Stock | F | — | A | $149.23 |
| BIIBBiogen Inc. Common Stock | B | D | B | $195.34 |
| BNTXBioNTech SE American Depositary Share | C | C | D | $88.08 |
| MRNAModerna, Inc. Common Stock | C | B | B | $47.44 |
| NBIXNeurocrine Biosciences Inc | C | B | B | $163.88 |
| EXELExelixis Inc | C | B | B | $52.70 |
| KRYSKrystal Biotech, Inc. Common Stock | D | B | A | $301.00 |
About
Humacyte develops acellular bioengineered tissues for regenerative medicine, focusing on vascular grafts and engineered organs for vascular trauma, peripheral arterial disease, and dialysis access. The company's pipeline includes tissue-engineered vessels and advanced organ systems designed to address significant patient needs across multiple therapeutic areas.